
NYSEHealthcareMedical - Instruments & Supplies
最新資料
US$225.98
+US$5.29 · +2.40%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
前收盤價
US$225.98
+US$5.29 · +2.40%
盤前
US$226.25
+US$0.27 · +0.12%
10月8日 上午4:03 ET
盤中時間採用ET。市場資料可能有所延遲。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日內區間
目前US$225.98
52週區間
目前US$225.98
盤中時間採用ET。市場資料可能有所延遲。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日內區間
目前US$225.98
52週區間
目前US$225.98
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 56.53億 USD | 51.46億 USD | 46.85億 USD | 42.23億 USD | 35.78億 USD |
| 銷貨成本 | 22.02億 USD | 20.91億 USD | 20.3億 USD | 18.67億 USD | 15.54億 USD |
| 毛利 | 34.52億 USD | 30.55億 USD | 26.55億 USD | 23.56億 USD | 20.24億 USD |
| 研究與開發 | 3.78億 USD | 3.31億 USD | 3.08億 USD | 2.88億 USD | 2.54億 USD |
| 銷售、一般及管理費用 | 11.2億 USD | 9.91億 USD | 9.17億 USD | 8.74億 USD | 7.39億 USD |
| 營業費用 | 15.43億 USD | 13.7億 USD | 13.35億 USD | 12.24億 USD | 10.24億 USD |
| 利息支出 | — | 1260.9萬 USD | 4570.8萬 USD | 4737.9萬 USD | 2231.2萬 USD |
| 折舊和攤銷 | 2.44億 USD | 2.36億 USD | 2.16億 USD | 1.98億 USD | 1.94億 USD |
| 營業利益 | 19.08億 USD | 16.85億 USD | 13.2億 USD | 11.32億 USD | 10億 USD |
| 淨利 | 15.23億 USD | 14.01億 USD | 10.21億 USD | 8.98億 USD | 7.79億 USD |
公司資料更新於 2026年10月8日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$242.7
上漲空間 7.40%年度分割調整後的每股現金分配。
US$2.26
2025年(完整年度)+39.5% 自從 2021
2026年(部分年度):US$1.86
US$1.62
2,021
US$1.72
2,022
US$1.84
2,023
US$2.02
2,024
US$2.26
2,025
US$1.86
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月20日 | US$0.66Quarterly | 2026年8月20日 | 2026年9月24日 |
股息 | 2026年5月14日 | US$0.60Quarterly | 2026年5月14日 | 2026年6月18日 |
股息 | 2026年2月12日 | US$0.60Quarterly | 2026年2月12日 | 2026年3月19日 |
股息 | 2025年11月13日 | US$0.60Quarterly | 2025年11月13日 | 2025年12月18日 |
股息 | 2025年8月14日 | US$0.60Quarterly | 2025年8月14日 | 2025年9月18日 |
股息 | 2025年5月8日 | US$0.53Quarterly | 2025年5月8日 | 2025年6月12日 |
除息 2026年8月20日
US$0.66
Quarterly
2026年8月20日登記 · 支付日 2026年9月24日
除息 2026年5月14日
US$0.60
Quarterly
2026年5月14日登記 · 支付日 2026年6月18日
除息 2026年2月12日
US$0.60
Quarterly
2026年2月12日登記 · 支付日 2026年3月19日
除息 2025年11月13日
US$0.60
Quarterly
2025年11月13日登記 · 支付日 2025年12月18日
除息 2025年8月14日
US$0.60
Quarterly
2025年8月14日登記 · 支付日 2025年9月18日
除息 2025年5月8日
US$0.53
Quarterly
2025年5月8日登記 · 支付日 2025年6月12日
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T612.07億0.05%129.41兆 JPY0.09%¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI11.07億0.05%2.3兆 USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO9.25億0.05%1.8兆 USD0.03%US$714.34-0.26%
Vanguard Morningstar Mid-Cap ETFVO7.53億0.33%2264億 USD0.03%US$80.14-1.04%
Vanguard Morningstar Growth ETFVUG4.44億0.12%3846億 USD0.03%US$92.42-0.24%
iShares Core S&P 500 ETFIVV4.24億0.05%8996.25億 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY3.87億0.05%8190.39億 USD0.09%US$777.22-0.24%
First Trust Rising Dividend Achievers ETFRDVY3.63億1.43%253.67億 USD0.47%US$78.87-0.74%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Vanguard Morningstar Growth ETFVUG
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
First Trust Rising Dividend Achievers ETFRDVYAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。